Ng-Kamstra, Joshua S. http://orcid.org/0000-0001-9335-2061
Rennert-May, Elissa
McKee, Jessica
Lundgren, Skyla
Manns, Braden
Kirkpatrick, Andrew W.
Funding for this research was provided by:
The Acelity Corporation (N/A)
Cumming School of Medicine, University of Calgary (N/A)
Article History
Received: 16 January 2020
Accepted: 7 February 2020
First Online: 21 February 2020
Ethics approval and consent to participate
: The COOL trial is currently approved by the Conjoint Research Ethics Board of the University of Calgary (REB-16-1588) to proceed with a delayed consent process given the time-sensitive critical nature of decision-making. Research ethics will vary throughout the world and it is anticipated that various local policies concerning community consent, waiver of consent, or informed consent of significant patient proxies will vary among the local approaches to ensure that the COOL trial is performed to the highest ethical standards on a global basis.
: Not applicable
: The authors declare that they have no competing interests.